Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enterobacteriaceae Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05138822
What this trial is testing

Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Who this might be right for
Uncomplicated Urinary Tract InfectionsUrinary Tract Infections
GlaxoSmithKline 140
Not applicableEnrolling By InvitationNCT07039955
What this trial is testing

Effect of Daily Chlorhexidine Bathing and Antibiotic/PPI Stewardship on Prevention of CPE Transmission and Infection

Who this might be right for
Carbapenemase-Producing Enterobacteriaceae (CPE)Healthcare-Associated Infections (HAIs)
Chuncheon Sacred Heart Hospital 5,760
Testing effectiveness (Phase 2)Looking for participantsNCT06702449
What this trial is testing

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

Who this might be right for
Urinary Tract Infections
GlaxoSmithKline 448
Early research (Phase 1)Study completedNCT03040687
What this trial is testing

Efficacy of B7A BSIgG Against E. Coli Strain B7A Challenge

Who this might be right for
Healthy Volunteer
Johns Hopkins Bloomberg School of Public Health 60
Not applicableStudy completedNCT04574596
What this trial is testing

Multi-Drug Resistant Organism (MDRO): Study of Highly Resistant Escherichia Coli

Who this might be right for
E Coli Infection
Duke University 300
Large-scale testing (Phase 3)UnknownNCT05771779
What this trial is testing

Co-administration Study of OCV, TCV and MR

Who this might be right for
TyphoidCholeraMeasles+1 more
International Centre for Diarrhoeal Disease Research, Bangladesh 2,117
Not applicableStudy completedNCT04167228
What this trial is testing

Impact of Ceftazidime / Avibactam Treatment vs Better Available Therapy on Mortality of Patients With Infections Caused by Carbapenem-resistant Enterobacteria

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Maimónides Biomedical Research Institute of Córdoba 348
Large-scale testing (Phase 3)Study completedNCT02795949
What this trial is testing

Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae

Who this might be right for
Enterobacteriaceae Infections
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 344
Early research (Phase 1)UnknownNCT05431673
What this trial is testing

Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma

Who this might be right for
Rhinoscleroma
Assiut University 45
Testing effectiveness (Phase 2)Study completedNCT06523231
What this trial is testing

Study to Expand Safety and Immunogenicity Data With Shigella Bioconjugate Vaccine (Shigella4V2) in 9-month-old Infants.

Who this might be right for
Shigellosis
LimmaTech Biologics AG 110
Testing effectiveness (Phase 2)Study completedNCT00498654
What this trial is testing

Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects

Who this might be right for
Typhoid Fever
Avant Immunotherapeutics 180
Not applicableStudy completedNCT05797103
What this trial is testing

The Research of Novel Electrolyzed Water Spray to Eradicate Bacteria E-coli and an Attenuated Human Flu Virus

Who this might be right for
Bacterial GrowthNovel Influenza A (H1N1)
Dove Medical Press Ltd 20
Not applicableStudy completedNCT03401242
What this trial is testing

Prevalence of ESBL and CPE in French Nursing Homes

Who this might be right for
Enterobacteriaceae Infections
Nantes University Hospital 734
Not applicableStudy completedNCT02420366
What this trial is testing

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Who this might be right for
Urinary Tract Infection, ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+2 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 257
Early research (Phase 1)Ended earlyNCT03548064
What this trial is testing

Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area

Who this might be right for
Gastroenteritis Escherichia ColiImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 75
Post-approval studies (Phase 4)Looking for participantsNCT03971669
What this trial is testing

Blood Donor CVD 5000

Who this might be right for
Risk Reduction
University of Maryland, Baltimore 150
Not applicableLooking for participantsNCT04535661
What this trial is testing

Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae Infection
Children's Hospital of Fudan University 536
Early research (Phase 1)Study completedNCT00097396
What this trial is testing

Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

Who this might be right for
Pneumonic PlaguePreventive Therapy
DynPort Vaccine Company LLC, A GDIT Company 40
Early research (Phase 1)Study completedNCT05409196
What this trial is testing

Phase 1 Trial for Safety, Tolerability, and Immunogenicity of a Live, Attenuated, Oral Shigella/ETEC Combination Vaccine to Healthy Adults

Who this might be right for
Diarrheal Disease, InfectiousGastrointestinal DiseaseReactive Arthritis
Eveliqure Biotechnologies GmbH 84
Post-approval studies (Phase 4)Study completedNCT00131820
What this trial is testing

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Who this might be right for
TyphoidParatyphoid Fever
International Vaccine Institute 100,742
Next Page